Knowledge

Endothelial dysfunction

Source đź“ť

316: 182: 25: 117: 132: 498:
Since NO maintains low tone and high compliance of the small arteries at rest, a reduction of age-dependent small artery compliance is a marker for endothelial dysfunction that is associated with both functional and structural changes in the microcirculation. Small artery compliance or stiffness can
569:. Calcium channel blockers and selective beta 1 antagonists may also improve endothelial dysfunction. Life style modifications such as smoking cessation have also been shown to improve endothelial function and lower the risk of major cardiovascular events. 386:
Nitric oxide (NO) suppresses platelet aggregation, inflammation, oxidative stress, vascular smooth muscle cell migration and proliferation, and leukocyte adhesion. A feature of endothelial dysfunction is the inability of
1312: 419:(BH4) supplementation has shown beneficial results for the treatment of endothelial dysfunction in animal experiments and clinical trials, although the tendency of BH4 to become oxidized to BH2 remains a problem. 1361:
Yuyun MF, Ng LL, Ng GA (2018). "Endothelial dysfunction, endothelial nitric oxide bioavailability, tetrahydrobiopterin, and 5-methyltetrahydrofolate in cardiovascular disease. Where are we with therapy?".
406:
from the endothelium like NO. Endothelial dysfunction is commonly associated with decreased NO bioavailability, which is due to impaired NO production by the endothelium or inactivation of NO by reactive
1848:
Unverdorben, Martin; Vallbracht, Christian; Cremers, Bodo; Heuer, Hubertus; Hengstenberg, Christian; Maikowski, Christian; Werner, Gerald S.; Antoni, Diethmar; Kleber, Franz X. (2009-06-16).
696:
Sitia, S.; Tomasoni, L.; Atzeni, F.; Ambrosio, G.; Cordiano, C.; Catapano, A.; Tramontana, S.; Perticone, F.; Naccarato, P. (2010). "From endothelial dysfunction to atherosclerosis".
1979:
Briasoulis A, Tousoulis D, Androulakis ES, Papageorgiou N, Latsios G, Stefanadis C (Apr 2012). "Endothelial dysfunction and atherosclerosis: focus on novel therapeutic approaches".
458:(FMD) as measured by Brachial Artery Ultrasound Imaging (BAUI). Current measurements of endothelial function via FMD vary due to technical and physiological factors. Furthermore, a 366:
are well known to contribute to endothelial dysfunction, and lowering blood pressure and LDL has been shown to improve endothelial function, particularly when lowered with
1677:
Gilani M, Kaiser DR, Bratteli CW, Alinder C, Rajala Bank AJ, Cohn JN (2007). "Role of nitric oxide deficiency and its detection as a risk factor in pre-hypertension".
302:, tightly controlled vascular permeability, and anti-thrombotic and anti-inflammatory properties. This balance ensures the smooth functioning of the vascular system. 462:
between percent flow mediated dilation and baseline artery size is recognised as a fundamental scaling problem, leading to biased estimates of endothelial function.
518:, but further investigation showed that they often impair endothelial function in humans and worsen conditions. One drug used to inhibit restenosis is 35: 731:
Flammer AJ, Anderson T, Celermajer DS, Creager MA, Deanfield J, Ganz P, Hamburg NM, LĂĽscher TF, Shechter M, Taddei S, Vita JA, Lerman A (Aug 2012).
1940:"Cardiovascular risk reduction by reversing endothelial dysfunction: ARBs, ACE inhibitors, or both? Expectations from the ONTARGET Trial Programme" 378:. Steadily laminar flow with high shear stress in blood vessels protects against atherosclerosis, whereas disturbed flow promotes atherosclerosis. 150: 491:
when compared against the gold standard, acetylcholine angiogram. This results suggests that this peripheral test reflects the physiology of the
849:
Maruhashi, T; Kihara, Y; Higashi, Y (2018). "Assessment of endothelium-independent vasodilation: From methodology to clinical perspectives".
1714:"Association of small artery elasticity with incident cardiovascular disease in older adults: the multiethnic study of atherosclerosis" 96: 68: 1450:
Thijssen DH, Black MA, Pyke KE, Padilla J, Atkinson G, Harris RA, Parker B, Widlansky ME, Tschakovsky ME, Green DJ (Jan 2011).
75: 1276: 1153: 897:"Functionally defective high-density lipoprotein and paraoxonase: a couple for endothelial dysfunction in atherosclerosis" 1149:"Mechanisms of Oxidized LDL-Mediated Endothelial Dysfunction and Its Consequences for the Development of Atherosclerosis" 604: 566: 82: 1638:"Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia" 649: 948:"Dysfunctional Vascular Endothelium as a Driver of Atherosclerosis: Emerging Insights Into Pathogenesis and Treatment" 1850:"Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis" 168: 64: 54: 499:
be assessed simply and at rest and can be distinguished from large artery stiffness by use of pulsewave analysis.
1712:
Duprez DA, Jacobs DR, Lutsey PL, Bluemke FA, Brumback LC, Polak JF, Peralta CA, Greenland P, Kronmal RA (2011).
1899:"Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies" 1401:"Flow mediated dilation of the brachial artery: an investigation of methods requiring further standardization" 340: 451: 287:. The result of this endothelial dysregulation is a cascade of adverse effects, including vasoconstriction, 476: 2068: 1399:
Peretz, Alon; Daniel F Leotta; Jeffrey H Sullivan; Carol A Trenga; Fiona N Sands; Mary R Aulet (2007).
534:
COVID-19 can present with an acute lung injury manifestation that arises from endothelial dysfunction.
268: 1761:
Cohn JN, Duprez DA, Finkelstein SM (2009). "Comprehensive noninvasive arterial vascular evaluation".
315: 89: 43: 327:
and may predate vascular pathology. Endothelial dysfunction may also lead to increased adherence of
2016:"Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis" 439:
responses to vasoactive agents may be used to test for endothelial function, and venous occlusion
488: 371: 336: 288: 146: 50: 39: 583: 455: 209: 1452:"Assessment of flow-mediated dilation in humans: a methodological and physiological guideline" 594: 465: 459: 412: 264: 240: 547: 492: 480: 428: 8: 785:"Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19" 469: 416: 510:
implantation has been correlated with impaired endothelial function in several studies.
1956: 1939: 1923: 1898: 1825: 1800: 1738: 1713: 1613: 1592: 1527: 1505: 1500: 1476: 1451: 1427: 1400: 1234: 1201: 1177: 1148: 1083: 1028: 974: 947: 923: 896: 874: 819: 784: 757: 732: 673: 644: 272: 1866: 1849: 748: 2045: 2037: 1996: 1961: 1879: 1871: 1830: 1778: 1743: 1694: 1659: 1618: 1573: 1532: 1481: 1432: 1398: 1381: 1340: 1332: 1290: 1282: 1272: 1239: 1221: 1182: 1129: 1075: 1067: 1020: 979: 928: 866: 824: 806: 762: 713: 678: 1257:
Konukoglu, Dildar; Uzun, Hafize (2017). "Endothelial Dysfunction and Hypertension".
1087: 1032: 2027: 1988: 1951: 1918: 1910: 1861: 1820: 1812: 1770: 1733: 1725: 1686: 1649: 1608: 1600: 1563: 1522: 1514: 1471: 1463: 1422: 1412: 1373: 1364: 1324: 1264: 1229: 1213: 1172: 1162: 1119: 1110: 1059: 1010: 999:"Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction" 969: 959: 918: 908: 878: 858: 814: 796: 783:
Bernard, Isabelle; Limonta, Daniel; Mahal, Lara K.; Hobman, Tom C. (January 2021).
752: 744: 705: 668: 658: 256: 236: 217: 190: 1552:"Assessment of peripheral vascular endothelial function in the ambulatory setting" 1518: 1263:. Advances in Experimental Medicine and Biology. Vol. 956. pp. 511–540. 1106:"Oxidized LDL and NO synthesis--Biomarkers of endothelial dysfunction and ageing" 862: 709: 578: 444: 440: 436: 324: 292: 1467: 2032: 2015: 1992: 1914: 1690: 1654: 1637: 1636:
Bonetti PO, Pumper GM, Higano ST, Holmes DR Jr, Kuvin JT, Lerman A (Dec 2004).
1328: 1063: 645:"Targeting Early Atherosclerosis: A Focus on Oxidative Stress and Inflammation" 562: 484: 399: 1377: 1124: 1105: 1015: 998: 964: 733:"The assessment of endothelial function: from research into clinical practice" 514:
eluting stents were previously used because they showed low rates of in-stent
2062: 2041: 1875: 1816: 1568: 1551: 1336: 1286: 1225: 1167: 1071: 810: 367: 280: 213: 1258: 1047: 487:'s EndoPAT. It has shown an 80% sensitivity and 86% specificity to diagnose 479:-approved device for measuring endothelial function that works by measuring 2049: 2000: 1965: 1883: 1834: 1782: 1747: 1698: 1663: 1622: 1577: 1536: 1485: 1436: 1417: 1385: 1344: 1294: 1243: 1186: 1133: 1079: 1024: 983: 932: 870: 828: 766: 717: 682: 663: 621: 599: 588: 543: 403: 363: 359: 299: 248: 221: 202: 201:. The main cause of endothelial dysfunction is impaired bioavailability of 1978: 1217: 913: 1801:"Recent advances to accelerate re-endothelialization for vascular stents" 1729: 1268: 558: 447:
are used to assess endothelial function of peripheral vessels in humans.
432: 229: 198: 181: 468:
is a marker of endothelial dysfunction, and is consistently elevated in
343:
is a hallmark feature of atherosclerosis, by promoting the formation of
609: 523: 515: 392: 351: 332: 284: 244: 225: 53:
if you can. Unsourced or poorly sourced material may be challenged and
1774: 801: 251:. This pathological state is often associated with elevated levels of 519: 511: 396: 344: 252: 1550:
Kuvin JT, Mammen A, Mooney P, Alsheikh-Ali AA, Karas RH (Feb 2007).
295:. These changes contribute to the progression of vascular diseases. 1593:"Assessing endothelial vasodilator function with the Endo-PAT 2000" 614: 388: 355: 348: 328: 276: 1847: 1604: 551: 260: 1313:"Hypertension and endothelial dysfunction: therapeutic approach" 1048:"Endothelial dysfunction in the pathogenesis of atherosclerosis" 730: 395:
to dilate fully in response to an appropriate stimulus, such as
319:
Stages of endothelial dysfunction in atherosclerosis of arteries
1635: 408: 375: 323:
Endothelial dysfunction may be involved in the development of
1799:
Bedair, T. M; Elnaggar, M. A; Joung, Y. K; Han, D. K (2017).
1549: 1311:
Ghiadoni, Lorenzo; Taddei, Stefano; Virdis, Agostino (2012).
555: 507: 185:
Comparison of healthy vs. dysfunctional vascular endothelium
16:
Impaired function of the inner lining of blood/lymph vessels
1676: 1501:"Endothelial function in patients with atrial fibrillation" 997:
MĂĽnzel T, Sinning C, Post F, Warnholtz A, Schulz E (2008).
695: 642: 291:, thrombosis, hyperinflammation, and a disrupted antiviral 1306: 1304: 996: 1711: 782: 1897:
Xu, Suo-wen; Ilyas, Iqra; Weng, Jian-ping (April 2023).
1449: 1301: 1798: 1498: 1260:
Hypertension: From basic research to clinical practice
848: 1937: 1760: 529: 502: 1310: 454:
method to measure endothelial dysfunction is %
1200:Le Master, Elizabeth; Levitan, Irena (2019-01-22). 1103: 141:
may be too technical for most readers to understand
2020:Arteriosclerosis, Thrombosis, and Vascular Biology 550:may improve endothelial function in people taking 1590: 212:, the endothelium is responsible for maintaining 2060: 1199: 2013: 1591:Axtell AL, Gomari FA, Cooke JP (October 2010). 1499:Khan AA, Thomas GN, Lip G, Shantsila A (2020). 1356: 1354: 1099: 1097: 894: 643:Marchio P, Guerra-Ojeda S, Mauricio MD (2019). 890: 888: 638: 636: 235:Dysfunctional endothelium is characterized by 220:by releasing mediators, such as nitric oxide, 49:Please review the contents of the article and 1256: 945: 298:In a healthy state, the endothelium exhibits 1931: 1584: 1492: 1351: 1140: 1094: 946:Botts SR, Fish JE, Howe KL (December 2021). 1896: 1146: 990: 885: 633: 2014:Messner, Barbara; Bernhard, David (2014). 1052:Clinical and Applied Thrombosis/Hemostasis 2031: 1955: 1938:Ruilope LM, RedĂłn J, Schmieder R (2007). 1922: 1865: 1824: 1737: 1653: 1612: 1567: 1526: 1475: 1426: 1416: 1360: 1233: 1176: 1166: 1123: 1014: 973: 963: 939: 922: 912: 818: 800: 756: 672: 662: 650:Oxidative Medicine and Cellular Longevity 169:Learn how and when to remove this message 153:, without removing the technical details. 1202:"Endothelial stiffening in dyslipidemia" 422: 314: 197:is a systemic pathological state of the 180: 1104:Gradinaru D, Borsa C, Prada GI (2015). 1045: 358:instability and ultimately to rupture. 335:, as well as promoting infiltration of 2061: 1794: 1792: 354:, and platelet activation, leading to 151:make it understandable to non-experts 1154:Frontiers in Cardiovascular Medicine 1111:Mechanisms of Ageing and Development 844: 842: 840: 838: 778: 776: 125: 18: 1944:Vascular Health and Risk Management 1789: 605:Endothelium-derived relaxing factor 567:angiotensin II receptor antagonists 13: 895:Eren E, Yilmaz N, Aydin O (2013). 554:(HMGCoA-reductase inhibitor), and 530:COVID-19 complication in the lungs 503:Endothelial dysfunction and stents 310: 14: 2080: 1981:Recent Pat Cardiovasc Drug Discov 1867:10.1161/circulationaha.108.839282 1597:Journal of Visualized Experiments 835: 773: 749:10.1161/circulationaha.112.093245 537: 130: 115: 23: 2007: 1972: 1890: 1841: 1754: 1705: 1670: 1629: 1543: 1456:Am J Physiol Heart Circ Physiol 1443: 1392: 1250: 1193: 381: 1147:Jiang M, Zhou Y, Ge J (2022). 1039: 724: 689: 51:add the appropriate references 1: 1805:Journal of Tissue Engineering 1519:10.1080/07853890.2019.1711158 1317:Current Vascular Pharmacology 627: 402:, that stimulates release of 1405:BMC Cardiovascular Disorders 863:10.1097/HJH.0000000000001750 710:10.1016/j.autrev.2010.07.016 411:species. As a co-factor for 7: 1468:10.1152/ajpheart.00471.2010 572: 561:system inhibitors, such as 305: 269:fibrin degradation products 228:, and by controlling local 208:In addition to acting as a 36:reliable medical references 10: 2085: 2033:10.1161/ATVBAHA.113.300156 1993:10.2174/157489012799362386 1915:10.1038/s41401-022-00998-0 1903:Acta Pharmacologica Sinica 1691:10.1016/j.jash.2006.11.002 1655:10.1016/j.jacc.2004.08.062 1329:10.2174/157016112798829823 1064:10.1177/107602960100700404 339:(LDL) in the vessel wall. 1378:10.1016/j.mvr.2018.03.012 1125:10.1016/j.mad.2015.03.003 1016:10.1080/07853890701854702 965:10.3389/fphar.2021.787541 952:Frontiers in Pharmacology 65:"Endothelial dysfunction" 42:or relies too heavily on 1817:10.1177/2041731417731546 1569:10.1177/1358863x06076227 1168:10.3389/fcvm.2022.925923 372:calcium channel blockers 851:Journal of Hypertension 489:coronary artery disease 337:low-density lipoprotein 195:endothelial dysfunction 1418:10.1186/1471-2261-7-11 1365:Microvascular Research 584:Endothelial activation 456:Flow-Mediated Dilation 320: 210:semipermeable membrane 186: 1218:10.18632/aging.101778 595:nitric oxide synthase 466:von Willebrand factor 423:Testing and diagnosis 413:nitric oxide synthase 318: 265:von Willebrand factor 241:vascular permeability 184: 1811:: 2041731417731546. 1269:10.1007/5584_2016_90 1046:Poredos, P. (2001). 698:Autoimmunity Reviews 664:10.1155/2019/8563845 548:hypercholesterolemia 460:negative correlation 429:coronary circulation 914:10.1155/2013/792090 470:atrial fibrillation 417:tetrahydrobiopterin 356:atheromatous plaque 283:(IL-6), and plasma 1730:10.1093/aje/kwr120 1506:Annals of Medicine 1003:Annals of Medicine 481:Reactive Hyperemia 321: 273:C-reactive protein 187: 2069:Vascular diseases 1860:(23): 2986–2994. 1775:10.2217/fca.09.44 1763:Future Cardiology 1642:J Am Coll Cardiol 1278:978-3-319-44250-1 802:10.3390/v13010029 191:vascular diseases 179: 178: 171: 124: 123: 100: 2076: 2054: 2053: 2035: 2011: 2005: 2004: 1976: 1970: 1969: 1959: 1935: 1929: 1928: 1926: 1894: 1888: 1887: 1869: 1845: 1839: 1838: 1828: 1796: 1787: 1786: 1758: 1752: 1751: 1741: 1709: 1703: 1702: 1674: 1668: 1667: 1657: 1633: 1627: 1626: 1616: 1588: 1582: 1581: 1571: 1547: 1541: 1540: 1530: 1496: 1490: 1489: 1479: 1447: 1441: 1440: 1430: 1420: 1396: 1390: 1389: 1358: 1349: 1348: 1308: 1299: 1298: 1254: 1248: 1247: 1237: 1197: 1191: 1190: 1180: 1170: 1144: 1138: 1137: 1127: 1101: 1092: 1091: 1043: 1037: 1036: 1018: 994: 988: 987: 977: 967: 943: 937: 936: 926: 916: 892: 883: 882: 857:(7): 1460–1467. 846: 833: 832: 822: 804: 780: 771: 770: 760: 728: 722: 721: 693: 687: 686: 676: 666: 640: 475:A non-invasive, 289:vascular leakage 257:prothrombin time 237:vasoconstriction 218:oxidative stress 174: 167: 163: 160: 154: 134: 133: 126: 119: 118: 110: 107: 101: 99: 58: 27: 26: 19: 2084: 2083: 2079: 2078: 2077: 2075: 2074: 2073: 2059: 2058: 2057: 2012: 2008: 1977: 1973: 1936: 1932: 1895: 1891: 1846: 1842: 1797: 1790: 1759: 1755: 1710: 1706: 1675: 1671: 1648:(11): 2137–41. 1634: 1630: 1589: 1585: 1548: 1544: 1497: 1493: 1448: 1444: 1397: 1393: 1359: 1352: 1309: 1302: 1279: 1255: 1251: 1198: 1194: 1145: 1141: 1102: 1095: 1044: 1040: 995: 991: 944: 940: 893: 886: 847: 836: 781: 774: 729: 725: 704:(12): 830–834. 694: 690: 641: 634: 630: 579:Atherosclerosis 575: 540: 532: 505: 483:Index (RHI) is 445:ultrasonography 441:plethysmography 437:coronary artery 425: 384: 325:atherosclerosis 313: 311:Atherosclerosis 308: 293:immune response 216:and regulating 175: 164: 158: 155: 147:help improve it 144: 135: 131: 120: 116: 111: 105: 102: 59: 48: 44:primary sources 28: 24: 17: 12: 11: 5: 2082: 2072: 2071: 2056: 2055: 2026:(3): 509–515. 2006: 1971: 1930: 1909:(4): 695–709. 1889: 1840: 1788: 1753: 1718:Am J Epidemiol 1704: 1669: 1628: 1583: 1542: 1491: 1442: 1391: 1350: 1300: 1277: 1249: 1212:(2): 299–300. 1192: 1139: 1093: 1058:(4): 276–280. 1038: 989: 938: 884: 834: 772: 723: 688: 631: 629: 626: 625: 624: 618: 612: 607: 602: 597: 591: 586: 581: 574: 571: 563:ACE inhibitors 539: 538:Risk reduction 536: 531: 528: 504: 501: 485:Itamar Medical 424: 421: 400:nitroglycerine 383: 380: 368:ACE inhibitors 312: 309: 307: 304: 232:-II activity. 177: 176: 138: 136: 129: 122: 121: 114: 112: 31: 29: 22: 15: 9: 6: 4: 3: 2: 2081: 2070: 2067: 2066: 2064: 2051: 2047: 2043: 2039: 2034: 2029: 2025: 2021: 2017: 2010: 2002: 1998: 1994: 1990: 1986: 1982: 1975: 1967: 1963: 1958: 1953: 1949: 1945: 1941: 1934: 1925: 1920: 1916: 1912: 1908: 1904: 1900: 1893: 1885: 1881: 1877: 1873: 1868: 1863: 1859: 1855: 1851: 1844: 1836: 1832: 1827: 1822: 1818: 1814: 1810: 1806: 1802: 1795: 1793: 1784: 1780: 1776: 1772: 1768: 1764: 1757: 1749: 1745: 1740: 1735: 1731: 1727: 1724:(5): 528–36. 1723: 1719: 1715: 1708: 1700: 1696: 1692: 1688: 1684: 1680: 1673: 1665: 1661: 1656: 1651: 1647: 1643: 1639: 1632: 1624: 1620: 1615: 1610: 1606: 1602: 1598: 1594: 1587: 1579: 1575: 1570: 1565: 1561: 1557: 1553: 1546: 1538: 1534: 1529: 1524: 1520: 1516: 1513:(1–2): 1–11. 1512: 1508: 1507: 1502: 1495: 1487: 1483: 1478: 1473: 1469: 1465: 1461: 1457: 1453: 1446: 1438: 1434: 1429: 1424: 1419: 1414: 1410: 1406: 1402: 1395: 1387: 1383: 1379: 1375: 1371: 1367: 1366: 1357: 1355: 1346: 1342: 1338: 1334: 1330: 1326: 1322: 1318: 1314: 1307: 1305: 1296: 1292: 1288: 1284: 1280: 1274: 1270: 1266: 1262: 1261: 1253: 1245: 1241: 1236: 1231: 1227: 1223: 1219: 1215: 1211: 1207: 1203: 1196: 1188: 1184: 1179: 1174: 1169: 1164: 1160: 1156: 1155: 1150: 1143: 1135: 1131: 1126: 1121: 1117: 1113: 1112: 1107: 1100: 1098: 1089: 1085: 1081: 1077: 1073: 1069: 1065: 1061: 1057: 1053: 1049: 1042: 1034: 1030: 1026: 1022: 1017: 1012: 1009:(3): 180–96. 1008: 1004: 1000: 993: 985: 981: 976: 971: 966: 961: 957: 953: 949: 942: 934: 930: 925: 920: 915: 910: 906: 902: 898: 891: 889: 880: 876: 872: 868: 864: 860: 856: 852: 845: 843: 841: 839: 830: 826: 821: 816: 812: 808: 803: 798: 794: 790: 786: 779: 777: 768: 764: 759: 754: 750: 746: 743:(6): 753–67. 742: 738: 734: 727: 719: 715: 711: 707: 703: 699: 692: 684: 680: 675: 670: 665: 660: 656: 652: 651: 646: 639: 637: 632: 623: 619: 616: 613: 611: 608: 606: 603: 601: 598: 596: 592: 590: 587: 585: 582: 580: 577: 576: 570: 568: 564: 560: 557: 553: 549: 545: 542:Treatment of 535: 527: 525: 521: 517: 513: 509: 500: 496: 495:endothelium. 494: 490: 486: 482: 478: 473: 471: 467: 463: 461: 457: 453: 448: 446: 442: 438: 434: 430: 420: 418: 414: 410: 405: 401: 398: 394: 390: 379: 377: 373: 369: 365: 361: 357: 353: 350: 346: 342: 338: 334: 330: 326: 317: 303: 301: 296: 294: 290: 286: 282: 281:Interleukin 6 278: 274: 270: 266: 262: 258: 254: 250: 246: 242: 238: 233: 231: 227: 223: 219: 215: 214:vascular tone 211: 206: 204: 200: 196: 192: 183: 173: 170: 162: 159:February 2022 152: 148: 142: 139:This article 137: 128: 127: 113: 109: 98: 95: 91: 88: 84: 81: 77: 74: 70: 67: â€“  66: 62: 61:Find sources: 56: 52: 46: 45: 41: 37: 32:This article 30: 21: 20: 2023: 2019: 2009: 1987:(1): 21–32. 1984: 1980: 1974: 1947: 1943: 1933: 1906: 1902: 1892: 1857: 1853: 1843: 1808: 1804: 1769:(6): 573–9. 1766: 1762: 1756: 1721: 1717: 1707: 1685:(1): 45–56. 1682: 1678: 1672: 1645: 1641: 1631: 1605:10.3791/2167 1596: 1586: 1559: 1555: 1545: 1510: 1504: 1494: 1462:(1): H2–12. 1459: 1455: 1445: 1408: 1404: 1394: 1369: 1363: 1323:(1): 42–60. 1320: 1316: 1259: 1252: 1209: 1205: 1195: 1158: 1152: 1142: 1115: 1109: 1055: 1051: 1041: 1006: 1002: 992: 955: 951: 941: 904: 900: 854: 850: 792: 788: 740: 736: 726: 701: 697: 691: 654: 648: 622:shear stress 620:Endothelial 600:Prostacyclin 593:endothelial 589:Nitric oxide 544:hypertension 541: 533: 506: 497: 474: 464: 452:non-invasive 449: 426: 404:vasodilators 385: 382:Nitric oxide 364:hypertension 360:Dyslipidemia 341:Oxidized LDL 322: 300:vasodilation 297: 249:inflammation 239:, increased 234: 222:prostacyclin 207: 203:nitric oxide 194: 188: 165: 156: 140: 103: 93: 86: 79: 72: 60: 40:verification 33: 1854:Circulation 1562:(1): 13–6. 1118:: 101–113. 901:Cholesterol 737:Circulation 657:: 8563845. 559:angiotensin 433:angiography 333:macrophages 230:angiotensin 199:endothelium 34:needs more 1950:(1): 1–9. 1411:(11): 11. 1161:: 925923. 958:: 787541. 907:: 792090. 628:References 610:Endothelin 524:paclitaxel 516:restenosis 393:arterioles 352:chemotaxis 345:foam cells 285:creatinine 253:biomarkers 245:thrombosis 226:endothelin 106:April 2018 76:newspapers 2042:1524-4636 1876:0009-7322 1556:Vasc. Med 1337:1875-6212 1287:0065-2598 1226:1945-4589 1072:1076-0296 811:1999-4915 795:(1): 29. 520:iopromide 512:Sirolimus 397:exogenous 329:monocytes 2063:Category 2050:24554606 2001:22280336 1966:17583170 1884:19487593 1835:28989698 1783:19886784 1748:21709134 1699:20409832 1664:15582310 1623:20972417 1578:17451088 1537:31903788 1486:20952670 1437:17376239 1386:29596860 1372:: 7–12. 1345:22112351 1295:28035582 1244:30674709 1187:35722128 1134:25804383 1088:71334997 1080:11697708 1033:18542183 1025:18382884 984:35002720 933:24222847 871:29664811 829:33375371 767:22869857 718:20678595 683:31354915 615:Integrin 573:See also 493:coronary 389:arteries 349:monocyte 306:Research 277:ferritin 255:such as 1957:1994043 1924:9574180 1826:5624345 1739:3202150 1614:3143035 1528:7877921 1477:3023245 1428:1847451 1235:6366977 1178:9199460 975:8727904 924:3814057 879:4948849 820:7823949 789:Viruses 758:3427943 674:6636482 617:network 552:statins 427:In the 376:statins 275:(CRP), 261:D-dimer 145:Please 90:scholar 55:removed 2048:  2040:  1999:  1964:  1954:  1921:  1882:  1874:  1833:  1823:  1781:  1746:  1736:  1697:  1662:  1621:  1611:  1599:(44). 1576:  1535:  1525:  1484:  1474:  1435:  1425:  1384:  1343:  1335:  1293:  1285:  1275:  1242:  1232:  1224:  1185:  1175:  1132:  1086:  1078:  1070:  1031:  1023:  982:  972:  931:  921:  877:  869:  827:  817:  809:  765:  755:  716:  681:  671:  409:oxygen 374:, and 247:, and 92:  85:  78:  71:  63:  1206:Aging 1084:S2CID 1029:S2CID 875:S2CID 556:renin 508:Stent 97:JSTOR 83:books 2046:PMID 2038:ISSN 1997:PMID 1962:PMID 1880:PMID 1872:ISSN 1831:PMID 1779:PMID 1744:PMID 1695:PMID 1679:JASH 1660:PMID 1619:PMID 1574:PMID 1533:PMID 1482:PMID 1433:PMID 1382:PMID 1341:PMID 1333:ISSN 1291:PMID 1283:ISSN 1273:ISBN 1240:PMID 1222:ISSN 1183:PMID 1130:PMID 1076:PMID 1068:ISSN 1021:PMID 980:PMID 929:PMID 905:2013 867:PMID 825:PMID 807:ISSN 763:PMID 714:PMID 679:PMID 655:2019 565:and 546:and 443:and 391:and 362:and 331:and 224:and 69:news 38:for 2028:doi 1989:doi 1952:PMC 1919:PMC 1911:doi 1862:doi 1858:119 1821:PMC 1813:doi 1771:doi 1734:PMC 1726:doi 1722:174 1687:doi 1650:doi 1609:PMC 1601:doi 1564:doi 1523:PMC 1515:doi 1472:PMC 1464:doi 1460:300 1423:PMC 1413:doi 1374:doi 1370:119 1325:doi 1265:doi 1230:PMC 1214:doi 1173:PMC 1163:doi 1120:doi 1116:151 1060:doi 1011:doi 970:PMC 960:doi 919:PMC 909:doi 859:doi 815:PMC 797:doi 753:PMC 745:doi 741:126 706:doi 669:PMC 659:doi 477:FDA 472:. 435:of 189:In 149:to 2065:: 2044:. 2036:. 2024:34 2022:. 2018:. 1995:. 1983:. 1960:. 1946:. 1942:. 1917:. 1907:44 1905:. 1901:. 1878:. 1870:. 1856:. 1852:. 1829:. 1819:. 1807:. 1803:. 1791:^ 1777:. 1765:. 1742:. 1732:. 1720:. 1716:. 1693:. 1681:. 1658:. 1646:44 1644:. 1640:. 1617:. 1607:. 1595:. 1572:. 1560:12 1558:. 1554:. 1531:. 1521:. 1511:52 1509:. 1503:. 1480:. 1470:. 1458:. 1454:. 1431:. 1421:. 1407:. 1403:. 1380:. 1368:. 1353:^ 1339:. 1331:. 1321:10 1319:. 1315:. 1303:^ 1289:. 1281:. 1271:. 1238:. 1228:. 1220:. 1210:11 1208:. 1204:. 1181:. 1171:. 1157:. 1151:. 1128:. 1114:. 1108:. 1096:^ 1082:. 1074:. 1066:. 1054:. 1050:. 1027:. 1019:. 1007:40 1005:. 1001:. 978:. 968:. 956:12 954:. 950:. 927:. 917:. 903:. 899:. 887:^ 873:. 865:. 855:36 853:. 837:^ 823:. 813:. 805:. 793:13 791:. 787:. 775:^ 761:. 751:. 739:. 735:. 712:. 700:. 677:. 667:. 653:. 647:. 635:^ 526:. 450:A 431:, 415:, 370:, 347:, 279:, 271:, 267:, 263:, 259:, 243:, 205:. 193:, 57:. 2052:. 2030:: 2003:. 1991:: 1985:7 1968:. 1948:3 1927:. 1913:: 1886:. 1864:: 1837:. 1815:: 1809:8 1785:. 1773:: 1767:5 1750:. 1728:: 1701:. 1689:: 1683:1 1666:. 1652:: 1625:. 1603:: 1580:. 1566:: 1539:. 1517:: 1488:. 1466:: 1439:. 1415:: 1409:7 1388:. 1376:: 1347:. 1327:: 1297:. 1267:: 1246:. 1216:: 1189:. 1165:: 1159:9 1136:. 1122:: 1090:. 1062:: 1056:7 1035:. 1013:: 986:. 962:: 935:. 911:: 881:. 861:: 831:. 799:: 769:. 747:: 720:. 708:: 702:9 685:. 661:: 522:- 172:) 166:( 161:) 157:( 143:. 108:) 104:( 94:· 87:· 80:· 73:· 47:.

Index

reliable medical references
verification
primary sources
add the appropriate references
removed
"Endothelial dysfunction"
news
newspapers
books
scholar
JSTOR
help improve it
make it understandable to non-experts
Learn how and when to remove this message

vascular diseases
endothelium
nitric oxide
semipermeable membrane
vascular tone
oxidative stress
prostacyclin
endothelin
angiotensin
vasoconstriction
vascular permeability
thrombosis
inflammation
biomarkers
prothrombin time

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑